NSEDCP
ENTA icon

NJ State Employees Deferred Compensation Plan’s Enanta Pharmaceuticals ENTA Stock Holding History

NJ State Employees Deferred Compensation Plan’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-12,500
Closed -$287K – 436
2013
Q3 		$287K Hold
12,500
– – 0.06% 346
2013
Q2 		$221K Buy
+12,500
New +$244K 0.05% 358

Other funds holding ENTA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
AP
AlpInvest Partners Amsterdam, Netherlands $49.7M AUM 23.93% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's ENTA Position: Q4 2013 in Review

NJ State Employees Deferred Compensation Plan sold out of Enanta Pharmaceuticals (ENTA) in Q4 2013, closing a stake of 12,500 shares — an estimated $287K sold.

NJ State Employees Deferred Compensation Plan first reported a position in ENTA in Q2 2013 and held it in 2 quarters. The position peaked at $287K in Q3 2013. 66 funds tracked by Wall St. Rank hold ENTA as of Q4 2013.

  • NJ State Employees Deferred Compensation Plan reported no remaining Enanta Pharmaceuticals position as of Q4 2013 after selling out during the quarter.
  • NJ State Employees Deferred Compensation Plan sold 12,500 Enanta Pharmaceuticals shares in Q4 2013, an estimated $287K.
  • NJ State Employees Deferred Compensation Plan first reported a position in Enanta Pharmaceuticals in Q2 2013 and held it in 2 quarters.
  • NJ State Employees Deferred Compensation Plan's Enanta Pharmaceuticals position peaked at $287K in Q3 2013.
  • 66 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q4 2013.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q4 2013, filed 10 Feb 2014.